SINGAPORE -- Cancer antibody developer Hummingbird Bioscience has received approval from Singapore health authorities to start a clinical trial for COVID-19 antibody therapy.
DealStreetAsia
Singapore Hummingbird to start COVID antibody therapy trial
SK-backed startup receives approval from local authorities